| 000 | 01082 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516225553.0 | ||
| 264 | 0 | _c20140909 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1527-3350 | ||
| 024 | 7 |
_a10.1002/hep.26918 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchäfer, Arne | |
| 245 | 0 | 0 |
_aReply: To PMID 23300053. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cJul 2014 |
||
| 300 |
_a431-2 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCognition Disorders _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 700 | 1 | _aKraus, Michael R | |
| 700 | 1 | _aScheurlen, Michael | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 60 _gno. 1 _gp. 431-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.26918 _zAvailable from publisher's website |
| 999 |
_c24081637 _d24081637 |
||